I-Hsiang Huang
Overview
Explore the profile of I-Hsiang Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
3
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hsieh H, Huang I, Chang S, Chen P, Su Y, Wang S, et al.
Autophagy
. 2024 Jan;
20(6):1335-1358.
PMID: 38261662
Bacterial pore-forming toxins (PFTs) that disrupt host plasma membrane integrity (PMI) significantly contribute to the virulence of various pathogens. However, how host cells protect PMI in response to PFT perforation...
2.
Ko J, Chen J, Hsieh J, Tseng P, Chiang C, Liu L, et al.
Biochem Pharmacol
. 2022 Aug;
204:115207.
PMID: 35961402
Elevated thymidine phosphorylase (TP) levels, a key enzyme in the pyrimidine nucleoside salvage pathway, in cancer cells, are related to a poor prognosis in a variety of cancers. Heat shock...
3.
Ko J, Chen J, Tseng P, Hsieh J, Chiang C, Liu L, et al.
Toxicol Res (Camb)
. 2022 May;
11(2):299-310.
PMID: 35510237
Nitroglycerin (NTG)-a nitric oxide-donating drug-is traditionally administered via the sublingual route to treat acute myocardial angina attacks. NTG also increases tumor blood flow and, consequently, cancer drug delivery to tumor...
4.
Ko J, Chen J, Wei C, Liu L, Chien C, Huang I, et al.
Pharmacology
. 2021 Nov;
106(11-12):623-636.
PMID: 34753130
Introduction: 5-Fluorouracil (5-FU) is used to treat various cancers, including non-small-cell lung cancer (NSCLC). It inhibits nucleotide synthesis and induces single- and double-strand DNA breaks. In the homologous recombination pathway,...